Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of RSD1235 versus placebo for rapid conversion of atrial fibrillation or atrial flutter to sinus rhythm
2004-000984-81Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) and atrial flutter (AFL) comparing RSD1235 with Placebo (2 arms). Started Jul 2004; status: completed.
02
Drugs
vernakalant
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2004-000984-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000984-81.